Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives: National intervention cooperative study in elderly hypertensives study group

Hypertension

Volumn 34, Issue 5, 1999, Pages 1129-1133

  Kuramoto, Kizuku ^a  

^a Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology   (Japan)

Author keywords

Calcium antagonist; Diuretics; Elderly; Hypertension

Indexed keywords

CALCIUM ANTAGONIST; DIURETIC AGENT; NICARDIPINE; TRICHLORMETHIAZIDE;

AGED; ARTICLE; BLOOD PRESSURE; CALCIUM ANTAGONISM; CARDIOVASCULAR RESPONSE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURESIS; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL;

EID: 0032748510     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.5.1129     Document Type: Article

References (19)

1. Kuramoto K, Matsushita S, Kuwajima I, Murakami M. Prospective study on the treatment of mild hypertension in the aged. Jpn Heart J. 1981;22: 75-85.
2. Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyterre M, De Schaepdryver A, Dollery C, Fagard R, Forette F, Forte J, Hamdy R, Henry JF, Joossens JV, Leonetti G, Lung-Johansen P, O'Malley K, Petrie J, Strasser T, Tuomilehto J, Williams B. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet. 1985;1:1349-1370.
3. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1991;265:3255-3264.
4. Dahlof A, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypenension). Lancet. 1991;338:1281-1285.
5. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ. 1992;304:405-412.
6. Gong L, Zhang W, Zhu Y, Zhu J, 11 collaborating centers in the Shanghai area, Kong D, Pagé V, Ghadirian P, LeLorier J, Hamet P. Shanghai Trial of Nifedipine in the Elderly (STONE). J Hypertens. 1996;14:1237-1245.
7. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Collery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350:757-764.
8. Liu L, Wang G, Gong L, Liu G, Staessen JA. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. J Hypertens. 1998;16:1823-1829.
9. Kuramoto K, and the National Intervention Cooperative Study Group. Treatment of elderly hypertensive in Japan: National Intervention Cooperative Study in Elderly Hypertensives. J Hypertens. 1994;12(suppl 6):S35-S40.
10. Psaty BM, Koepsell TD, Yanez ND, Smith NL, Manolio TA, Heckbert SR, Borhani NO, Gardin JM, Gottdiener JS, Rutan GH, Siscovick DS, Furberg CD. Temporal patterns of antihypertensive medication use among older adults, 1989 through 1992: an effect of the major clinical trials on clinical practice? JAMA. 1995;273:1436-1438.
11. Staessen JA, Thijs L, Fagard RH, Birkenhager WH, Arabidze G, Babeanu S, Gil-Extremera B, Bulpitt CJ, Davidson C, de Leeuw PW, Efstratopoulos AD, Fletcher AE, Fogari R, Jaaskivi M, Kawecka-Jaszcz K, Nachev C, Petrie JC, Seux ML, Tuomilehto J, Webster J, Yodfat Y. Calcium channel blockade and cardiovascular prognosis in the European Trial on isolated systolic hypertension. Hypertension. 1998;32:410-416.
12. Furberg CD, Psaty BM, Meyer JV. Nifedipine dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995;92: 1326-1331.
13. Psaty BM, Heckbert SR, Koepsell TD, Sicovick DS, Raghunathan TE, Weiss NS, Rosendaal FR, Lemaitre RN, Smith NL, Wahl PW, Wagner EH, Furberg CD. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 1995;274:620-625.
14. Alderman MH, Cohen H, Roque R, Madhavan S. Effect of long acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet. 1997;349:594-598.
15. Pahor MP, Guralnik JM, Salive ME, Corti MC, Carbonin P, Havlik RJ. Do calcium channel blockers increase the risk of cancer? Am J Hypertens. 1996;9:695-699.
16. Pahor M, Guralnik JM, Ferrucci L, Corti MC, Salive ME, Cerhan JR, Wallace RB, Havlik RJ. Calcium-channel blockade and incidence of cancer in aged population. Lancet. 1996;348:493-497.
17. Pahor M, Guralnik JM, Furberg CD, Carbonin P, Havlik RJ. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet. 1996;347:1061-1065.
18. Borhani NO, Mercuri M, Borhani PA, Buckalew VM, Canossa-Terris M, Carr AA, Kappagoda T, Rocco MV, Schnaper HW, Sowers JR, Bond G. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS.): a randomized controlled trial. JAMA. 1996;276: 785-791.
19. Savage PJ, Pressel SL, Curb JD, Schron EB, Applegate WB, Black HR, Cohen J, Davis BR, Frost P, Smith W, Gonzalez N, Guthrie GP, Oberman A, Rutan G, Probstfield JL, Stamler J, for the SHEP Cooperative Research Group. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the Systolic Hypertension in the Elderly Program. Arch Intern Med. 1998;158-741-751.